Condition: Colorectal Cancer · Quality of Life · Survivorship · Sponsor: University of Aarhus
Over the last decades, the 3-year recurrence rates for patients with stage I and II colorectal cancer have decreased to just 5% and 12%. The follow-up program offered to stage I and low-risk stage II patients has not changed accordingly and is still focused solely on recurrence detection. Moreover, it is a one-size-fits-all program, i.e. most of the follow-up resources are spent on non-recurrence patients who do not benefit. Up to 50% of cancer survivors suffer from reduced quality of life related to fear of cancer recurrence, treatment-related psychological distress, and/or severe late adverse effects of a biopsychosocial and/or organ-specific origin. Today many of these symptoms can be treated effectively. However, no systematic program aimed at monitoring and addressing the symptoms has been implemented yet. The current project is testing a newly developed, digitally managed, patient-centered follow-up program that focuses on individual patient needs, including fear of cancer recurrence, psychological well-being, management of late adverse effects, and recurrence surveillance. This new program will be compared to the current standard of care in a national network of 11 colorectal cancer surgical centers in four of five Danish regions. Patients in the intervention group will receive the following: 1. Risk-stratified circulating tumor DNA (ctDNA) guided recurrence surveillance. 2. Late adverse effects monitoring with electronic patient-reported outcome measures, which ar…
This description comes directly from the study's public registry record.
Claus L Andersen, Prof. · +45 78455319 · cla@clin.au.dk
Mai-Britt W Ørntoft, Ass. Prof. · +45 78432424 · mwo@clin.au.dk
Always discuss trial participation with your own doctor first.
| Gødstrup Hospital | Herning, Central Jutland, Denmark | Recruiting |
| Regional Hospital Randers | Randers, Central Jutland, Denmark | Recruiting |
| Aalborg University Hospital | Aalborg, North Denmark, Denmark | Recruiting |
| Odense University Hospital | Odense, The Region of Southern Denmark, Denmark | Recruiting |
| Svendborg Sygehus | Svendborg, The Region of Southern Denmark, Denmark | Recruiting |
| Aarhus University Hospital | Aarhus, Denmark | Recruiting |
| Bispebjerg Hospital | Copenhagen, Denmark | Recruiting |
| Regional Hospital Horsens | Horsens, Denmark | Recruiting |
| Regional Hospital Viborg | Viborg, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06614647